Вы искали: relapsed (Английский - Мальтийский)

relapsed
rikaduti

relapsed sclc
sclc li reġa’ feġġ

proportion relapsed
proporzjon li rkadew

relapsed ovarian cancer
kanċer ovarjan li rkada

proportion of subjects relapsed
proporzjon ta’ individwi li rkadew

relapsed/refractory follicular lymphoma
limfoma follikulari li rkadat/reġgħet tfaċċat

retreatment of patients with relapsed multiple myeloma
trattament mill-ġdid ta’ pazjenti b’majeloma multipla rikaduta

clinical efficacy in relapsed or refractory multiple myeloma
effikaċja klinika f’majeloma multipla li rkadiet jew refrattorja

failed to respond or relapsed following treatment with conventional chemotherapy
kienu naqsu milli jirrispondu jew

pts who had failed to respond or relapsed following treatment with fludarabine
(flimkien ma ’ pll) li kienu naqsu milli jirrispondu jew

all but one patients who died of tuberculosis had not converted or had relapsed.
il-pazjenti kollha ħlief wieħed li mietu minn tuberkolosi ma kinux ikkonvertu jew irkadew.

limited information on bortezomib retreatment in relapsed multiple myeloma is available.
informazzjoni ristretta disponibbli dwar it-trattament mill-ġdid bi bortezomib f’majeloma multipla li rkadiet

no paediatric subjects with svr relapsed during the 5 years of follow-up.
l-ebda individwu pedjatriku b’svr ma rkada matul il-5 snin ta’ segwitu.

a supplementary retrospective analysis was conducted on data from 523 patients with relapsed ovarian cancer.
analiżi retrospettiva supplimentari saret fuq it-tagħrif minn 523 pazjent li kellhom kanċer ovarjan li rkada.

figure 2 kaplan-meier curve of interim overall survival in relapsed multiple myelomaa
figura 2 kurva ta’ kaplan-meier tas-sopravivenza globali interim ta’ mijeloma multipla li reġgħet feġġeta

hycamtin has also been studied in three main studies in 656 patients with relapsed small cell lung cancer.
hycamtin ġie studjat ukoll fi tliet studji ewlenin li fihom ħadu sehem 656 pazjent b' kanċer tal- pulmun taċ- ċelluli żgħar reċidiv.

ra was shown to be effective in treating hepatitis c in both treatment-naïve and relapsed adults.
ad Ġiet osservata wkoll reazzjoni għat- trattament waqt il- vista ta ’ kontroll li saret sitt xhur wara sena ta ’ trattament f’ 46% tat- tfal, meta introna kienet użata flimkien ma ribavirin. ’ għ x’ inhu r- riskju assoċjat ma ’ viraferon?

for therapy of patients with relapsed or refractory non-hodgkin’s lymphoma not responding to rituximab
għal terapija ta’ pazjenti b’limfoma mhux ta’ hodgkin li rkadiet jew refrattarja li mhux qed tirrispondi għal rituximab

acute renal failure was reported more frequently in patients with advanced relapsed and refractory multiple myeloma who received kyprolis monotherapy.
insuffiċjenza akuta tal-kliewi kienet irrapportata aktar frekwentement f’pazjenti b’mijeloma multipla avvanzata li reġgħet feġġet u reżistenti meta ngħataw kyprolis waħdu.

1 includes reactivation and primary infections; frequency based on r-fc regimen in relapsed/refractory cll
1 tinkludi attivazzjoni mill-ġdid u infezzjonijiet primarji; frekwenza ibbażata fuq kors ta’ r-fc f’cll li reġgħet tfaċċat/ma rrispondietx għat-trattament